1 / 17

Mycobacterium florentinum , a new species isolated from humans

Mycobacterium florentinum , a new species isolated from humans. Enrico Tortoli. M. simiae -related mycobacteria. Slow growth Short helix 18 in the 16S rDNA Known organisms until 1993: M. simiae 2004: 13 species. The strains.

kin
Télécharger la présentation

Mycobacterium florentinum , a new species isolated from humans

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Mycobacterium florentinum, a new species isolated from humans Enrico Tortoli

  2. M. simiae-related mycobacteria • Slow growth • Short helix 18 in the 16S rDNA • Known organisms • until 1993: M. simiae • 2004: 13 species

  3. The strains • 1. isolated twice from the sputum of an elderly patient with lung cancer • 2. isolated twice from the sputum of an elderly patient with hemoptysis • 3. isolated from the stools of an AIDS patient • 4. isolated from the excised lymph node of a child with cervical lymphadenitis • 5. isolated three times from the sputum of an elderly patient with pulmonary disease • 6. isolated four times from the sputum of a patient, long hospitalized in intensive care due to pneumonia imputed to pneumococcus • 7. isolated twice, at four year interval, from the sputum of an elderly woman with fibrosis and bronchiectasis

  4. The strains • 1. isolated twice from the sputum of an elderly patient with lung cancer • 2. isolated twice from the sputum of an elderly patient with hemoptysis • 3. isolated from the stools of an AIDS patient • 4. isolated from the excised lymph node of a child with cervical lymphadenitis • 5. isolated three times from the sputum of an elderly patient with pulmonary disease • 6. isolated four times from the sputum of a patient, long hospitalized in intensive care due to pneumonia imputed to pneumococcus • 7. isolated twice, at four year interval, from the sputum of an elderly woman with fibrosis and bronchiectasis

  5. Biochemical and cultural features • Growth: at 25-37°C in two weeks • Colonies: smooth, creamy, nonchromogenic • Positive biochemical tests: urea hydrolysis, tellurite reduction • Negative biochemical tests: niacin, Tween 80 hydrolysis, 3-d arylsulfatase, β-glucosidase • Variable biochemical tests: nitrate reduction, semiquantitative catalase • Growth inhibited on: Mac Conkey agar, 5% NaCl Lowenstein Jensen • Growth not inhibited on: p-nitrobenzoate, isoniazid, hydroxylamine and oleate

  6. GLC pattern M. lentiflavum M. triplex FI-93171 24:0 > 26:0 20:0 > 22:0 18:0 > TBSA

  7. HPLC pattern M. simiae FI-93171

  8. HPLC pattern

  9. Antimicrobial susceptibility • Full susceptibility to clarithromycin and clofazimine only • High MICs of quinolones and rifamycins

  10. Genetic sequencing • 16S rDNA: 8 nucleotide mismatch with M. triplex • ITS: 14 nucleotide mismatch with M. triplex

  11. Phylogenetic tree FI-93171

  12. PRA patterns BstE III Hae III Haa I 1 2 3 1 2 3 1 2 3 1. FI-93171 2. M. lentiflavum 3. M. triplex

  13. A previous report

  14. colonies biochem. GLC HPLC PRA 16S + ITS phylogeny M. triplex M. lentiflavum similarity high low none M. florentinum sp. nov. • Most closely related species: • M. triplex • M. lentiflavum

  15. colonies biochem. GLC HPLC PRA 16S + ITS phylogeny M. triplex M. lentiflavum similarity high low none M. florentinum sp. nov. • Most closely related species: • M. triplex • M. lentiflavum

  16. Contributors Carlo Garzelli Laura Rindi Department of Experimental Pathology, University of Pisa, Pisa, Italy Nalin Rastogi K. S. Goh TB and Mycobacteria Unit, Institut Pasteur of Guadeloupe, Pointe a Pitre, Guadeloupe, France Gianna Mazzarelli Alessandro Mariottini Laboratory of Microbiology, Careggi Hospital, Florence, Italy Pirjo Torkko Laboratory of Environmental Microbiology, National Public Health Institute, Kuopio, Finland Marija-Leena Katila Department of Clinical Microbiology, Kuopio University Hospital, Kuopio, Finland

More Related